Newsroom

OLDWICK, N.J.--(BUSINESS WIRE)--Foreign currency exchange gains against the U.S. dollar have enabled Munich Re and Lloyd’s to reach the top echelon in AM Best’s companion rankings of the world’s largest reinsurers, which differ based on accounting standards. Munich Re has reclaimed the top position among IFRS 17 reporting reinsurers, driven in part by the Euro’s strong performance compared to the U.S. dollar. Meanwhile, Lloyd’s moved to the top of the ranking for non-IFRS 17 reinsurers, lifted...

BELOIT, Wis.--(BUSINESS WIRE)--Fairbanks Morse Defense (FMD), a portfolio company of Arcline Investment Management, today announced a 6.98 million euro investment in the expansion of the Vestdavit production facility in Redzikowo, Poland in partnership with the Pomeranian Regional Development Agency (PARR). The site will serve as FMD's global Davit Manufacturing Centre of Excellence (DMCoE), providing localised support to NATO and European naval forces, while producing the advanced systems need...

TOKYO--(BUSINESS WIRE)--Enhertu Showed Statistically Significant & Clinically Meaningful PFS Improvement as First-Line Treatment of Patients with HER2 Mutant Advanced NSCLC...

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 14 August 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback   Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 14 August 2026 Number of Public Shares Purchased: 29,4...

VILLEJUIF, France--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics (FR0010095596 - ALVIO), société de biotechnologie au stade clinique, pionnière dans le domaine des thérapies de précision de nouvelle génération («Valerio» ou la « Société »), fait un point sur le projet d’acquisition de 100% du capital social d’Etherna Immunotherapies NV (« Etherna ») (l’« Acquisition »). Le 1er juillet 2026, Valerio a annoncé avoir soumis une offre ferme en vue de l’Acquisition sur la base d’une valeur...

VILLEJUIF, France--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics (FR0010095596 - ALVIO), a biotechnology company pioneering next-generation precision-guided RNA therapeutics ("Valerio" or the "Company"), provides an update on the contemplated acquisition of 100% of the share capital of Etherna Immunotherapies NV ("Etherna") (the "Acquisition"). On July 1, 2026, Valerio announced the submission of a binding offer for the Acquisition on the basis of an enterprise value of EUR 30 million....

LONDON--(BUSINESS WIRE)--  First Trust Global Portfolios Management Limited (“FTGPM”) announces the declaration of the monthly distribution for First Trust Vest S&P 500® Dividend Aristocrats Target Income UCITS ETF (the “Fund”). ISIN Fund Name Frequency Dividend per Share IE000SNMGYT5 First Trust Vest S&P 500® Dividend Aristocrats Target Income UCITS ETF Class B Monthly $0.1493 (USD) The Fund’s investment manager is First Trust Advisors L.P. (“FTA”). FTA has appointed Vest Financial LLC...

BELLEVUE, Wash.--(BUSINESS WIRE)--As Lala moves west across Hawaiʻi, T‑Mobile (NASDAQ: TMUS) teams are expanding response and recovery efforts across the islands, restoring connectivity, supporting customers and working alongside emergency officials as communities begin to recover. Restoring Connectivity Across Hawaiʻi Network impacts have shifted as Lala has continued west, driven overwhelmingly by widespread commercial power outages. Crews are in the field across multiple islands restoring af...

AUSTIN, Texas--(BUSINESS WIRE)--New Pied Piper subscription programs identify customer-handling problems as they occur, and proactively alert local management when action is needed....

LOS ANGELES--(BUSINESS WIRE)--EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with SBS Law...